Storage Condition
Store at freezer (-20°C) for long term storage
Synonyms
Ivermectin B1 Mono-sugar Derivative, 71837-27-9
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
No -Refer MSDS for accurate information
Ivermectin B1 Mono-sugar Derivative is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Ivermectin B1 Mono-sugar Derivative usage and description
Ivermectin B1 Mono-sugar Derivative is a chemical compound that is widely used as an anti-parasitic agent in both human and veterinary medicine. It is a derivative of the well-known drug Ivermectin, which is commonly used to treat various parasitic infections in animals and humans, including scabies and river blindness.
Ivermectin B1 Mono-sugar Derivative is a semi-synthetic compound that is produced by chemically modifying the parent compound, Ivermectin. The modification involves the addition of a sugar molecule to the parent compound, which enhances its pharmacological properties, including its solubility in water.
The chemical structure of Ivermectin B1 Mono-sugar Derivative is complex, containing multiple rings and functional groups. It is a macrocyclic lactone compound that acts by binding to specific receptors in the nervous system of parasites, leading to their paralysis and death.
Ivermectin B1 Mono-sugar Derivative is mainly used in the treatment of parasitic infections such as onchocerciasis (river blindness), strongyloidiasis (intestinal infection), and scabies. It is also used in veterinary medicine to treat various parasitic infections in animals.
The safety and efficacy of Ivermectin B1 Mono-sugar Derivative have been extensively studied, and it is generally considered a safe and effective drug for the treatment of parasitic infections. However, like all drugs, it may cause side effects, including gastrointestinal disturbances, headache, and dizziness. It is important to use this drug only under the guidance of a healthcare professional.
